Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Medicis Pharmaceutical Corporation
Lobbying Relationship
Bills mentioned
S.214: Preserve Access to Affordable Generics Act
Sponsor: Amy Klobuchar (D-Minn.)
S.27: Preserve Access to Affordable Generics Act
Sponsor: Herb Kohl (D-Wis.)
H.R.3995: Protecting Consumer Access to Generic Drugs Act of 2012
Sponsor: Bobby L. Rush (D-Ill.)
H.R.1706: Protecting Consumer Access to Generic Drugs Act of 2009
Sponsor: Bobby L. Rush (D-Ill.)
S.369: Preserve Access to Affordable Generics Act
Sponsor: Herb Kohl (D-Wis.)
H.R.4899: Supplemental Appropriations Act, 2010
Sponsor: David R. Obey (D-Wis.)
S.1082: Food and Drug Administration Revitalization Act
Sponsor: Edward M. Kennedy (D-Mass.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Steve Symms | U.S. Senator, 1981 to 1993 |
| Edward Baxter | Chief Counsel and Staff Director, Senate Judiciary Committee's Subcommittee on Patents, Copyrights and Trademarks: 1987 to 1990 |
| Romano Romani | n/a |
| Dennis DeConcini | n/a |
| John Haddow | n/a |
| James Rock | n/a |
| Thaddeus Strom | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate